Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Monoclonal antibodies for treatment of human non-small cell lung carcinomas

Monoclonal antibodies for treatment of human non-small cell lung carcinomas

US Patent 5091177 · Granted Feb 25, 1992

Estimated economic value: $29,410,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Methods and compositions for preventing type 1 diabetes2024
Oligonucleotides for treating expanded repeat diseases2023
Induced exon inclusion in spinal muscle atrophy2020
Methods of treatment using CTLA4 mutant molecules2019
Oligonucleotides for treating expanded repeat diseases2018
Induced exon inclusion in spinal muscle atrophy2018
Diagnosis and prognosis of breast cancer patients2018
Compositions and methods of use for determination of HE4a2017
Compositions and methods of use for determination of HE4a2017
Methods of treatment using CTLA4 mutant molecules2017
Previewing search results2017
Methods and compositions for regulating cell cycle progression2015